Equities

Augmedix Inc

AUGX:NAQ

Augmedix Inc

Actions
Health CareHealth Care Providers
  • Price (USD)1.21
  • Today's Change-0.02 / -1.63%
  • Shares traded1.04m
  • 1 Year change-68.89%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.

  • Revenue in USD (TTM)48.70m
  • Net income in USD-20.43m
  • Incorporated2018
  • Employees1.43k
  • Location
    Augmedix Inc111 Sutter Street, Suite 1300SAN FRANCISCO 94104United StatesUSA
  • Phone+1 (561) 989-2208
  • Fax+1 (845) 818-3588
  • Websitehttps://augmedix.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
RM2 International Inc84.00m-9.05m34.22m530.00--0.335721.110.4073-0.3878-0.5833.600.89370.95985.637.53158,496.20-10.34-4.58-13.40-5.947.4217.07-10.77-5.450.6557-0.1220.6837---16.793.789.10--44.45--
Pixie Dust Technologies Inc(ADR)5.43m-14.33m36.31m116.00------6.69-2.03-2.030.5369--0.17812.0412.4146,812.14-46.99---57.54--71.72---263.90--2.04--0.3159--10.76---77.16------
Creative Realities Inc47.51m-2.05m38.55m152.00--1.3431.160.8114-0.2905-0.29055.122.760.712710.855.81312,546.10-3.07-8.41-5.27-11.9748.1244.96-4.31-10.660.34210.37870.4476--4.1914.98-256.56--67.22--
The9 Ltd (ADR)24.79m-18.95m38.87m50.00--1.14--1.57-9.82-6.485.286.100.3719--1,729.36495,747.40-29.97-42.70-103.60---18.35-7.92-80.58-242.27----0.2689--65.7059.3480.13--56.25--
Podcastone Inc-100.00bn-100.00bn40.51m41.00--2.46----------0.7123----------------------------0.00--35.69---10.42------
Data Storage Corp24.96m381.57k42.17m51.00113.362.0826.341.690.05340.05343.562.911.05--10.48489,403.501.26-4.551.51-5.8938.3738.901.20-4.47----0.0265--4.5622.94108.7621.0685.80--
Gorilla Technology Group Inc-100.00bn-100.00bn46.19m244.00--0.7646----------6.94------------------------1.49--0.347---46.95---924.03------
Metalpha Technology Holding Ltd5.69m-12.31m54.68m43.00--5.29--9.61-0.4559-0.76040.21090.27980.1416--1.18132,373.30-29.64-32.35-110.71-62.9735.50---209.40-355.43---183.620.0153--4,538.635.87-9.45---70.64--
Tancheng Group Co Ltd1.97m-289.68k54.81m17.00------27.84-0.0661-0.06610.4494-0.27281.12----115,828.80-16.55------18.33---14.71--0.4524------------------
Augmedix Inc48.70m-20.43m59.25m1.43k--3.32--1.22-0.4262-0.42621.020.36451.05--5.9834,054.55-44.12-56.08-79.63-104.8948.2244.31-41.95-74.05---19.890.535--45.0132.9121.59--55.49--
Alpha Technology Group Ltd1.11m-895.57k59.68m18.00--20.86--53.58-0.0676-0.06760.07890.1874----------------32.75---80.41-----90.550.0821--96.55---162.33------
Gryphon Digital Mining Inc11.72m-17.77m62.84m3.00------5.36-13.94-22.321.40-0.32650.9463--37.193,907,917.00-143.47------38.69---151.61------2.17---49.90--85.56------
Velo3D Inc77.44m-135.14m64.68m237.00--0.8259--0.8352-0.679-0.6790.39240.26450.4111.574.21326,763.70-71.72---95.80---33.92---174.50--1.18--0.3273---1.60---1,795.81------
MoneyHero Ltd80.67m-172.60m85.16m366.00--1.05--1.06-4.32-4.322.072.05------220,412.70--------45.54---213.95-----0.40530.0076--18.40---249.10------
Data as of May 17 2024. Currency figures normalised to Augmedix Inc's reporting currency: US Dollar USD

Institutional shareholders

60.90%Per cent of shares held by top holders
HolderShares% Held
Redmile Group LLCas of 31 Mar 202416.38m33.61%
Samjo Management LLCas of 31 Mar 20243.96m8.12%
Citadel Advisors LLCas of 31 Mar 20241.85m3.80%
Perkins Capital Management, Inc.as of 31 Mar 20241.46m2.99%
The Vanguard Group, Inc.as of 31 Mar 20241.29m2.64%
Balyasny Asset Management LPas of 31 Mar 20241.18m2.42%
Parkman Healthcare Partners LLCas of 31 Mar 20241.07m2.19%
Millennium Management LLCas of 31 Mar 20241.04m2.14%
Rhenman & Partners Asset Management ABas of 31 Mar 2024800.00k1.64%
Russell Investment Management LLCas of 31 Mar 2024657.05k1.35%
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.